93 related articles for article (PubMed ID: 5495795)
1. [Serologic survey of children in Mexico City. IV. Study of measles antibodies].
Gutiérrez G; Ruiz-Gómez J; Bustamante ME; Alvarez MT
Gac Med Mex; 1970 Nov; 100(11):1169-84. PubMed ID: 5495795
[No Abstract] [Full Text] [Related]
2. Serological survey of measles in Yemen in 1985.
Strauss J; Dobahi SS; Danes L; Kopecký K; Svandová E
J Hyg Epidemiol Microbiol Immunol; 1989; 33(1):71-4. PubMed ID: 2723425
[TBL] [Abstract][Full Text] [Related]
3. [Dynamics of the serologic response of children vaccinated with live AMN USSR measles vaccine prepared from the ESzCz strain].
Sinjak KM; Czumakow MP; Rodin WI; Czudnaja LM; Sziechtier AB; Winograd IA; Urin AI; Glinskaja LA; Szwiec LT; Knjaziewa II; Niemiec ZA
Przegl Epidemiol; 1970; 24(1):15-20. PubMed ID: 5431385
[No Abstract] [Full Text] [Related]
4. Prevalence of measles antibodies before and after vaccination in previously unvaccinated children of the Cordillera Province (Santa Cruz Department, Bolivia).
Guglielmetti P; Bianchi Bandinelli ML; Bartoloni A; Gamboa H; Roselli M; Valensin PE
J Trop Med Hyg; 1994 Aug; 97(4):231-5. PubMed ID: 8064946
[TBL] [Abstract][Full Text] [Related]
5. [Measles vaccination using Schwarz strain: clinical, serologic and electroencephalographic study].
Fourrier A; Beaussart M; Camier P; Lacombe A
Pediatrie; 1969; 24(1):97-8. PubMed ID: 5385115
[No Abstract] [Full Text] [Related]
6. [Serologic survey in children of Mexico City. VII. Study of antibodies against Entamoeba histolytica].
Gutiérrez-Trujillo G; Aubanel M
Arch Invest Med (Mex); 1972; 2():Suppl 2:371-6. PubMed ID: 4349098
[No Abstract] [Full Text] [Related]
7. [Vaccination against measles with Schwarz vaccine. Clinical, serologic and electroencephalographic results in 50 children].
Fourrier A; Beaussart M; Camier P; Lacombe A
Lille Med; 1968 Oct; 13(8):848-63. PubMed ID: 5743597
[No Abstract] [Full Text] [Related]
8. The role of herd immunity in control of measles.
Black FL
Yale J Biol Med; 1982; 55(3-4):351-60. PubMed ID: 7180027
[TBL] [Abstract][Full Text] [Related]
9. The elimination of indigenous measles transmission in England and Wales.
Ramsay ME; Jin L; White J; Litton P; Cohen B; Brown D
J Infect Dis; 2003 May; 187 Suppl 1():S198-207. PubMed ID: 12721914
[TBL] [Abstract][Full Text] [Related]
10. [Comparative study of 3 measles vaccines. IV. Evaluation of effectiveness on the basis of epidemiologic observations].
Przegl Epidemiol; 1971; 25(1):1-10. PubMed ID: 5088689
[No Abstract] [Full Text] [Related]
11. Measles epidemiology and its implications for a vaccination programme in Oman.
Patel PK; Al-Awaidy ST; Bawikar S; Al-Busaidy S; Al-Mahrooqi S
East Mediterr Health J; 2008; 14(3):579-89. PubMed ID: 18720622
[TBL] [Abstract][Full Text] [Related]
12. Measles in Mexico, 1941-2001: interruption of endemic transmission and lessons learned.
Santos JI; Nakamura MA; Godoy MV; Kuri P; Lucas CA; Conyer RT
J Infect Dis; 2004 May; 189 Suppl 1():S243-50. PubMed ID: 15106118
[TBL] [Abstract][Full Text] [Related]
13. [Comparative value of 3 anti-measles vaccines with attenuated live virus. Immuno-epidemiological study].
Topciu V; Arion R; Moldovan E; Csaky N; Olaru G
Arch Roum Pathol Exp Microbiol; 1971 Mar; 30(1):119-27. PubMed ID: 5096857
[No Abstract] [Full Text] [Related]
14. Importance of accurate diagnosis in the assessment of impact of immunisation campaigns: case study of a measles immunisation programme in Madagascar.
Garry SF
Public Health; 2009 Jan; 123(1):72-3. PubMed ID: 19049839
[No Abstract] [Full Text] [Related]
15. [Unsuitability of children revaccination against measles].
Bolotovskiĭ VM; Titova NS
Sov Med; 1981; (9):43-8. PubMed ID: 7313794
[No Abstract] [Full Text] [Related]
16. Population immunity to measles in the United States, 1999.
Hutchins SS; Bellini WJ; Coronado V; Jiles R; Wooten K; Deladisma A
J Infect Dis; 2004 May; 189 Suppl 1():S91-7. PubMed ID: 15106096
[TBL] [Abstract][Full Text] [Related]
17. Studies on further attenuated live measles vaccine. IV. Clinical and serological evaluation of a clone of CAM-CEF measles vaccine virus.
Ueda S; Takahashi M; Kurimura T; Ogino T; Suzuki N
Biken J; 1970 Sep; 13(3):169-74. PubMed ID: 5530511
[No Abstract] [Full Text] [Related]
18. Distinguishing between primary measles infection and vaccine failure reinfection by IgG avidity assay.
Hamkar R; Mahmoodi M; Nategh R; Jelyani KN; Eslami MB; Mohktari-Azad T
East Mediterr Health J; 2006 Nov; 12(6):775-82. PubMed ID: 17333822
[TBL] [Abstract][Full Text] [Related]
19. [Measles vaccination: study of humoral immunity in children vaccinated in the Tunis region].
Arrouji A; Mirchamsy H; Marnissi A
Arch Inst Pasteur Tunis; 1982 Mar; 59(1):173-80. PubMed ID: 7181563
[No Abstract] [Full Text] [Related]
20. Optimal age for vaccinating Zimbabwean children against measles. 1. Maternal and transplacentally transmitted measles antibodies in infancy.
Mhere OT; Mhlanga GE; Spencer HR
Cent Afr J Med; 1984 Oct; 30(10):187-9. PubMed ID: 6518490
[No Abstract] [Full Text] [Related]
[Next] [New Search]
